Featured Latest news

India Approves Novo Nordisk’s Wegovy for Fatty Liver Disease Treatment

By Uniquetimesorg July 18, 2026 0

India’s drug regulator has approved Novo Nordisk’s obesity drug Wegovy for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease. The approval covers the 2.4 mg semaglutide injection and marks another significant milestone for the blockbuster drug, which is already approved in India for chronic weight Continue Reading

Featured Latest News

India Cracks Down on Fake Mounjaro Pens

By Uniquetimesorg April 20, 2026 0

Indian regulators have seized more than 260 suspected counterfeit pens of Mounjaro, a popular treatment developed by Eli Lilly and Company. Authorities in Haryana arrested two individuals accused of manufacturing and distributing the fake drugs near New Delhi, uncovering an illegal operation run without a pharmaceutical licence. Investigators said the accused sourced raw Continue Reading

Featured Latest news

Sanofi to Expand Hyderabad GCC, Workforce to Cross 4,500

By Uniquetimesorg February 17, 2026 0

French drugmaker Sanofi announced plans to expand its global capability centre (GCC) in Hyderabad, increasing its workforce to more than 4,500 employees from the current 2,600. The expansion will be backed by a multi-hundred-million-dollar investment, though the company did not disclose a specific timeline for hiring. In 2024, Sanofi had committed to investing 400 million Continue Reading

Business Featured Latest News

Eli Lilly Launches Mounjaro Kwikpen in India, Intensifying Weight-Loss Drug Market Rivalry

By Uniquetimesorg August 13, 2025 0

Eli Lilly has introduced its easy-to-use Mounjaro Kwikpen in India, priced at ₹14,000 (about $160) for the starting 2.5 mg dose, aiming to strengthen its foothold in the booming weight-loss drug segment. The launch follows regulatory approval in June, just two days after rival Novo Nordisk rolled out its Wegovy pen device in multiple dose […]Continue Reading